Overview of analytical methods for determining novel psychoactive substances, drugs and their metabolites in biological samples

References

• Adamowicz P, Tokarczyk B. 2016. Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry. Drug Test Anal. 8(7):652–667.
   PubMed Web of Science ®Google Scholar
• Aldlgan AA, Torrance HJ. 2016. Bioanalytical methods for the determination of synthetic cannabinoids and metabolites in biological specimens. TrAC - Trends Anal Chem. 80:444–457.
   Web of Science ®Google Scholar
• Alexandridou A, Mouskeftara T, Raikos N, Gika HG. 2020. GC-MS anaysis of underivatised new psychoactivesubstances in whole blood and urine. J Chromatogr B Analyt Technol Biomed Life Sci. 1156:122308.
   PubMedGoogle Scholar
• Barroso M, Costa S, Dias M, Vieira DN, Queiroz JA, Lopez-Rivadulla M. 2010. Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatographymass spectrometry. J Chromatogr A. 1217(40):6274–6280.
   PubMed Web of Science ®Google Scholar
• Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, et al. 2013. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive “bath salts” products. Neuropsychopharmacology. 38(4):552–562.
   PubMed Web of Science ®Google Scholar
• Blough BE, Landavazo A, Decker AM, Partilla JS, Baumann MH, Rothman RB. 2014. Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes. Psychopharmacology (Berl). 231(21):4135–4144.
   PubMed Web of Science ®Google Scholar
• Buszewski B, Szultka M, Gadzała-Kopciuch R. 2012. Sorbent chemistry, evolution, in: Comprehensive Sampling and Sample Preparation. Analytical Techniques for Scientists. Ed J Pawliszyn. Elsevier. 2:243–256.
   Google Scholar
• Buszewski B, Szultka M 2012. Past, Present, and Future of Solid Phase Extraction: A Review. Crit Rev Anal Chem. 42(3):198–213.
   Web of Science ®Google Scholar
• Brandt SD, King LA, Evans-Brown M. 2014. Evans-Brown M. The new drug phenomenon. Drug Test Anal. 6(7–8):587–597.
   PubMed Web of Science ®Google Scholar
• Cannaert A, Storme J, Franz F, Auwarter V, Stove CP. 2016. Detection and activity profiling of synthetic cannabinoids and metabolites with a newly developed bio-assay. Anal Chem. 88(23):11476–11485.
   PubMed Web of Science ®Google Scholar
• Cohen K, Weinstein A. 2018. The effects of cannabinoids on executive functions: evidence from cannabis and synthetic cannabinoids—a systematic review. Brain Sci. 8(3):40.
   PubMed Web of Science ®Google Scholar
• Concheiro M, Anizan S, Ellefsen K, Huestis MA. 2013. Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry. Anal Bioanal Chem. 405(29):9437–9448.
   PubMed Web of Science ®Google Scholar
• Cozzi NV, Gopalakrishnan A, Anderson LL, Feih JT, Shulgin AT, Daley PF, Ruoho AE. 2009. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. J Neural Transm (Vienna). 116(12):1591–1599.
   PubMed Web of Science ®Google Scholar
• Dalsgaard PW, Rasmussen BS, Muller IB, Linnet K. 2012. Toxicological screening of basic drugs in whole blood using UPLC-TOF-MS. Drug Test Analysis. 4(5):313–319.
   PubMed Web of Science ®Google Scholar
• Debruyne D, Le Boisselier R. 2015. Emerging drugs of abuse: current perspectives on synthetic cannabinoids. Subst Abuse Rehabil. 6(6):113–129.
   PubMedGoogle Scholar
• Elie L, Baron M, Croxton R, Elie M. 2012. Microcrystalline identification of selected designer drugs. Forensic Sci Int. 214(1–3):182–188.
   PubMed Web of Science ®Google Scholar
• Eshleman AJ, Wolfrum EK, Hatfield MG, Johnson RA, Murphy KV, Janowsky A. 2013. Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol. 85(12):1803–1815.
   PubMed Web of Science ®Google Scholar
• Fels H, Herzog J, Skopp G, Holzer A, Paul LD, Graw M, Musshoff F. 2020. Retrospective analysis of new psychoactive substances in blood samples of German drivers suspected of driving under the influence of drugs. Drug Test Anal. 12(10):1470–1476.
   PubMed Web of Science ®Google Scholar
• Fleckenstein AE, Gibb JW, Hanson GR. 2000. Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur J Pharmacol. 406(1):1–13.
   PubMed Web of Science ®Google Scholar
• Franz F, Angerer V, Hermanns-Clausen M, Auwarter V, Moosmann B. 2016. Metabolites of synthetic cannabinoids in hair-proof of consumption or false friends for interpretation? Anal Bioanal Chem. 408(13):3445–3452.
   PubMed Web of Science ®Google Scholar
• Frison G, Frasson S, Zancanaro F, Tedeschi G, Zamengo L. 2016. Detection of 3-methylmethcathinone and its metabolites 3-methylephedrine and 3-methylnorephedrine in pubic hair samples by liquid chromatography-high resolution/high accuracy Orbitrap mass spectrometry. Forensic Sci Int. 265:131–137.
   PubMed Web of Science ®Google Scholar
• Gottardo R, Sorio D, Musile G, Trapani E, Seri C, Serpelloni G, Tagliaro F. 2014. Screening for synthetic cannabinoids in hair by using LC-QTOF MS: a new and powerful approach to study the penetration of these new psychoactive substances in the population. Med Sci Law. 54(1):22–27.
   PubMed Web of Science ®Google Scholar
• Halberstadt AL, Geyer MA. 2011. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology. 61(3):364–381.
   PubMed Web of Science ®Google Scholar
• Halberstadt AL, Koedood L, Powell SB, Geyer MA. 2011. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. J Psychopharmacol. 25(11):1548–1561.
   PubMed Web of Science ®Google Scholar
• Hurst T. 2019. World drug report. https://doi.org/10.1002/9781118929803.ewac0543.
   Google Scholar
• Hutter M, Kneisel S, Auwarter V, Neukamm MA. 2012. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 903:95–101.
   PubMed Web of Science ®Google Scholar
• Imbert L, Dulaurent S, Mercerolle M, Morichon J, Lachatre G, Gaulier JM. 2014. Development and validation of a single LCMS/MS assay following SPE for simultaneous hair analysis ofamphetamines, opiates, cocaine and metabolites. Forensic Sci Int. 234:132–138.
   PubMed Web of Science ®Google Scholar
• Institóris L, Kovacs K, Sija E, Berkecz R, Körmöczi T, Nemeth I, Elek I, Bakos A, Urban I, Pap C, et al. 2022. Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018–19). Clin Toxicol. 60(1):18–24.
   PubMed Web of Science ®Google Scholar
• Kerrigan S, Banuelos S, Perrella L, Hardy B. 2011. Simultaneous detection of ten psychedelic phenethylamines in urine by gas chromatography-mass spectrometry. J Anal Toxicol. 35(7):459–469.
   PubMed Web of Science ®Google Scholar
• Kerrigan S, Mellon MB, Banuelos S, Arndt C. 2011. Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines. J Anal Toxicol. 35(7):444–451.
   PubMed Web of Science ®Google Scholar
• Kim J, In S, Park Y, Park M, Kim E, Lee S. 2013. Deposition of JWH-018, JWH-073 and their metabolites in hair and effect of hair pigmentation. Anal Bioanal Chem. 405(30):9769–9778.
   PubMed Web of Science ®Google Scholar
• Kim J, Park Y, Park M, Kim E, Yang W, Baeck S, Lee S, Han S. 2015. Simultaneous determination of five naphthoylindole-based synthetic cannabinoids and metabolites and their deposition in human and rat hair. J Pharm Biomed Anal. 102:162–175.
   PubMed Web of Science ®Google Scholar
• Kneisel S, Auwärter V. 2012. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J Mass Spectrom. 47(7):825–835.
   PubMed Web of Science ®Google Scholar
• Lendoiro E, Jimenez-Morigosa C, Cruz A, Paramo M, Lopez-Rivadulla M, de Castro A. 2017. An LC-MS/MS methodological approach to the analysis of hair for amphetamine-type-stimulant (ATS) drugs, including selected synthetic cathinones and piperazines. Drug Test Analysis. 9(1):96–105.
   PubMed Web of Science ®Google Scholar
• Lõpez-Arnau R, Martínez-Clemente J, Pubill D, Escubedo E, Camarasa J. 2012. Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol. 167(2):407–420.
   PubMed Web of Science ®Google Scholar
• Lowdon JW, Alkirkit SMO, Mewis RE, Fulton D, Banks CE, Sutcliffe OB, Peeters M. 2018. Engineering molecularly imprinted polymers (MIPs) for the selective extraction and quantification of the Novel Psychoactive Substance (NPS) methoxphenidine and its regioisomers. Analyst. 143(9):2002–2007.
   PubMed Web of Science ®Google Scholar
• Lowdon JW, Eersels K, Rogosic R, Boonen T, Heidt B, Diliën H, van Grinsven B, Cleij TJ. 2019. Surface grafted molecularly imprinted polymeric receptor layers forthermal detection of the New Psychoactive substance2-methoxphenidine. Sens Actuat A. 295:586–595.
   Web of Science ®Google Scholar
• Maher WA, Pianca DJ, Apollonio LG, Whittall IR, Kyd JM. 2007. Matrix effect and cross-reactivity of select amphetamine-type substances, designer analogues, and putrefactive amines using the bio-quant direct ELISA presumptive assays for amphetamine and methamphetamine. J Anal Toxicol. 31(4):208–213.
   PubMed Web of Science ®Google Scholar
• Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH. 2014. Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology. 87:206–213.
   PubMed Web of Science ®Google Scholar
• Maurer HH, Meyer MR. 2016. High-resolution mass spectrometry in toxicology: current status and future perspectives. Arch Toxicol. 90(9):2161–2172.
   PubMed Web of Science ®Google Scholar
• Meltzer PC, Butler D, Deschamps JR, Madras BK. 2006. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem. 49(4):1420–1432.
   PubMed Web of Science ®Google Scholar
• Meyer MR, Caspar A, Brandt SD, Maurer HH. 2014. A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches. Anal Bioanal Chem. 406(1):225–237.
   PubMed Web of Science ®Google Scholar
• Meyer MR, Maurer HH. 2012. Current applications of high-resolution mass spectrometry in drug metabolism studies. Anal Bioanal Chem. 403(5):1221–1231.
   PubMed Web of Science ®Google Scholar
• Meyer MR, Maurer HH. 2016. Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - Where do we stand today? Anal Chim Acta. 927:13–20.
   PubMed Web of Science ®Google Scholar
• Michely JA, Helfer AG, Brandt SD, Meyer MR, Maurer HH. 2015. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC–MS, LC–MSn, and LC–HR–MS–MS. Anal Bioanal Chem. 407(25):7831–7842.
   PubMed Web of Science ®Google Scholar
• Montenarh D, Hopf M, Warth S, Maurer HH, Schmidt P, Ewald AH. 2015. A simple extraction and LC-MS/MS approach for the screening and identification of over 100 analytes in eight different matrices. Drug Test Anal. 7(3):214–240.
   PubMed Web of Science ®Google Scholar
• Mueller CA, Weinmann W, Dresen S, Schreiber A, Gergov M. 2005. Development of a multi-target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid Commun Mass Spectrom. 19(10):1332–1338.
   PubMed Web of Science ®Google Scholar
• Namera A, Urabe S, Saito T, Torikoshi-Hatano A, Shiraishi H, Arima Y, Nagao M. 2013. A fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of α-pyrrolidinobutiophenone and α-pyrrolidinovalerophenone in blood and/or hair. Forensic Toxicol. 31(2):338–343.
   Web of Science ®Google Scholar
• Nichols DE. 2012. Structure-activity relationships of serotonin 5-HT2A agonists. WIREs Membr Transp Signal. 1(5):559–579.
   Google Scholar
• Nieddu M, Burrai L, Trignano C, Boatto G. 2014a. Cross-reactivities of 39 new amphetamine designer drugs on three abuse drugs urinary screening tests. Forensic Toxicol. 32(1):132–138.
   Web of Science ®Google Scholar
• Nieddu M, Burrai L, Trignano C, Boatto G. 2014b. Evaluation of commercial multi-drug oral fluid devices to identify 39 new amphetamine-designer drugs. Leg Med. 16(2):106–109.
   PubMed Web of Science ®Google Scholar
• Nieddu M, Trignano C, Burrai L, Pirisi MA, Boatto G. 2013. Cross-reactivities of 41 new amphetamine designer drugs to EMIT®immunoassays. Forensic Toxicol. 31(1):133–137.
   Web of Science ®Google Scholar
• Nieddu M, Burrai L, Baralla E, Pasciu V, Varoni MV, Briguglio I, Demontis MP, Boatto G, et. al. 2016. ELISA detection of 30 new amphetamine designer drugs in whole blood, urine and oral fluid using neogen® “amphetamine” and “methamphetamine/MDMA” kits. J Anal Toxicol. 40(7):492–497.
   PubMed Web of Science ®Google Scholar
• O’Connor LC, Torrance HJ, McKeown DA. 2016. ELISA detection of phenazepam, etizolam, pyrazolam, flubromazepam, diclazepam and delorazepam in blood using Immunalysis® Benzodiazepine kit. J Anal Toxicol. 40(2):159–161.
   PubMed Web of Science ®Google Scholar
• Ojanperä I, Kolmonen M, Pelander A. 2012. Current use of highresolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Anal Bioanal Chem. 403(5):1203–1220.
   PubMed Web of Science ®Google Scholar
• Papoutsis II, Athanaselis SA, Nikolaou PD, Pistos CM, Spiliopoulou CA, Maravelias CP. 2010. Development and validation of an EI-GC-MS method for the determination of benzodiazepine drugs and their metabolites in blood: applications in clinical and forensic toxicology. J Pharm Biomed Anal. 52(4):609–614.
   PubMed Web of Science ®Google Scholar
• Pasin D, Cawley A, Bidny S, Fu S. 2017. Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review. Anal Bioanal Chem. 409(25):5821–5836.
   PubMed Web of Science ®Google Scholar
• Pellegrini M, Marchei E, Papaseit E, Farré M, Zaami S. 2020. UHPLC-HRMS and GC-MS screening of a selection of synthetic cannabinoids and metabolites in urine of consumers. Medicina. 56(8):408.
   PubMedGoogle Scholar
• Philp M, Shimmon R, Stojanovska N, Tahtouh M, Fu S. 2013. Development and validation of a presumptive colour spot test method for the detection of piperazine analogues in seized illicit materials. Anal Methods. 5(20):5402–5410.
   Web of Science ®Google Scholar
• Regester LE, Chmiel JD, Holler JM, Vorce SP, Levine B, Bosy TZ. 2015. Determination of designer drug cross-reactivity on five commercial immunoassay screening kits. J Anal Toxicol. 39(2):144–151.
   PubMed Web of Science ®Google Scholar
• Remane D, Wissenbach DK, Peters FT. 2016. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology – an update. Clin Biochem. 49(13–14):1051–1071.
   PubMed Web of Science ®Google Scholar
• Rojek S, Korczyńska-Albert M, Kulikowska J, Kłys M. 2017. Współczesne wyzwania w toksykologii związane z nowymi substancjami psychoaktywnymi ilustrowane przypadkami zgonów po zażyciu UR-144 oraz UR-144 z pentedronem oznaczonych w próbkach krwi metodą LC-ESI-MS (Contemporary challenges in toxicology related to new psychoactive substances illustrated by cases of deaths after taking UR-144 and UR-144 with pentedrone determined in blood samples using the LC-ESI-MS method) Arch Med. Arch Med Sadowej Kryminol. 67(2):104–120.
   PubMedGoogle Scholar
• Rust KY, Baumgartner MR, Dally AM, Kraemer T. 2012. Prevalence of new psychoactive substances: a retrospective study in hair. Drug Test Anal. 4(6):402–408.
   PubMed Web of Science ®Google Scholar
• Salomone A, Gerace E, D'Urso F, Di Corcia D, Vincenti M. 2012. Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples. J Mass Spectrom. 47(5):604–610.
   PubMed Web of Science ®Google Scholar
• Salomone A, Luciano C, Di Corcia D, Gerace E, Vincenti M. 2014. Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers. Drug Test Anal. 6(1–2):126–134.
   PubMed Web of Science ®Google Scholar
• Salomone A, Gazzilli G, Di Corcia D, Gerace E, Vincenti M. 2016. Determination of cathinones and other stimulant, psychedelic, and dissociative designer drugs in real hair samples. Anal Bioanal Chem. 408(8):2035–2042.
   PubMed Web of Science ®Google Scholar
• Salomone A, Palamar JJ, Gerace E, Di Corcia D, Vincenti M. 2017. Hair testing for drugs of abuse and new psychoactive substances in a high-risk population. J Anal Toxicol. 41:376–381.
   PubMed Web of Science ®Google Scholar
• Salomone A, Di Corcia D, Negri P, Kolia M, Amante E, Gerace E, Vincenti M. 2021. Targeted and untargeted detection of fentanyl analogues and their metabolites in hair by means of UHPLC-QTOF-HRMS. Anal Bioanal Chem. 413(1):225–233.
   PubMed Web of Science ®Google Scholar
• Sánchez-González J, Odoardi S, Bermejo AM, Bermejo-Barrera P, Romolo FS, Moreda-Piñeiro A, Strano-Rossi S. 2019. HPLC-MS/MS combined with membrane protected - molecularly imprinted polymer micro-solid-phase extraction for synthetic cathinones monitoring in urine. Drug Test Anal. 11(1):33–44.
   PubMed Web of Science ®Google Scholar
• Sánchez-González J, García-Carballal S, Cabarcos P, Tabernero MJ, Bermejo-Barrera P, Moreda PA. 2016. Determination of cocaine and its metabolites in plasma by porous membrane-protected molecularly imprinted polymer micro-solid-phase extraction and liquid chromatography—tandem mass spectrometry. J Chromatogr A. 1451:15–22.
   PubMed Web of Science ®Google Scholar
• Sánchez-González J, Salgueiro-Fernández R, Cabarcos P, Bermejo AM, Bermejo-Barrera P, Moreda-Pineiro A. 2017. Cannabinoids assessment in plasma and urine by high performance liquid chromatography–tandem mass spectrometry after molecularly imprinted polymer microsolid-phase extraction. Anal Bioanal Chem. 409(5):1207–1220.
   PubMed Web of Science ®Google Scholar
• Sánchez-González J, Tabernero MJ, Bermejo AM, Bermejo-Barrera P, Moreda-Piñeiro A. 2015. Porous membrane-protected molecularly imprinted polymer microsolid-phase extraction for analysis of urinary cocaine and its metabolites using liquid chromatography - tandem mass spectrometry. Anal Chim Acta. 898:50–59.
   PubMed Web of Science ®Google Scholar
• Scheidweiler KB, Jarvis MJY, Marilyn AH. 2015. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry. Anal Bioanal Chem. 407(3):883–897.
   PubMed Web of Science ®Google Scholar
• Shah SA, Deshmukh NI, Barker J, Petroczi A, Cross P, Archer R, Naughton DP. 2012. Quantitative analysis of mephedrone using liquid chromatography tandem mass spectroscopy: application to human hair. J Pharm Biomed Anal. 61:64–69.
   PubMed Web of Science ®Google Scholar
• Shen WW. 1997. The metabolism of psychoactive drugs: a review of enzymatic biotransformation and inhibition. Biol Psychiatry. 41(7):814–826.
   PubMed Web of Science ®Google Scholar
• Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME. 2013. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol. 168(2):458–470.
   PubMed Web of Science ®Google Scholar
• Simmler LD, Rickli A, Hoener MC, Liechti ME. 2014. Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology. 79:152–160.
   PubMed Web of Science ®Google Scholar
• Smith JP, Metters JP, Irving C, Sutcliffe OB, Banks CE. 2014. Forensic electrochemistry: the electroanalytical sensing of synthetic cathinone-derivatives and their accompanying adulterants in “legal high” products. Analyst. 139(2):389–400.
   PubMed Web of Science ®Google Scholar
• Smith JP, Metters JP, Khreit OIG, Sutcliffe OB, Banks CE. 2014. Forensic electrochemistry applied to the sensing of new psychoactive substances: electroanalytical sensing of synthetic cathinones and analytical validation in the quantification of seized street samples. Anal Chem. 86(19):9985–9992.
   PubMed Web of Science ®Google Scholar
• Strano-Rossi S, Odoardi S, Fisichella M, Anzillotti L, Gottardo R, Tagliaro F. 2014. Screening for new psychoactive substances in hair by ultrahigh performance liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr A. 1372c:145–156.
   Web of Science ®Google Scholar
• Swortwood MJ, Hearn WL, Decaprio AP. 2014. Cross-reactivity of designer drugs, including cathinone derivatives, in commercial enzyme-linked immunosorbent assays. Drug Test Analysis. 6(7–8):716–727.
   PubMed Web of Science ®Google Scholar
• Swortwood MJ, Boland DM, Decaprio AP. 2013. Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS Analysis. Anal Bioanal Chem. 405(4):1383–1397.
   PubMed Web of Science ®Google Scholar
• Szukalski B. 2001. Analysis of psychoactive substances in biological material. Alcohol Drug Addict. 14(l):151–163.
   Google Scholar
• Tang MHY, Ching CK, Lee CYW, Lam Y, Mak TWL. 2014. Simultaneous detection of 93 conventional and emerging drugs of abuse and their metabolites in urine by UHPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 969:272–284.
   PubMed Web of Science ®Google Scholar
• Tomczak E, Woźniak MK, Kata M, Wiergowski M, Szpiech B, Biziuk M. 2018. Blood concentrations of a new psychoactive substance 4-chloromethcathinone (4-CMC) determined in 15 forensic cases. Forensic Toxicol. 36(2):476–485.
   PubMed Web of Science ®Google Scholar
• Tyrkko E, Andersson M, Kronstrand R. 2016. The toxicology of new psychoactive substances: Synthetic cathinones and phenylethylamines. Ther Drug Monit. 38(2):190–216.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime (UNODC). 2014. World drug report 2014. Vienna, Austria: United Nations Publication, Sales No. E.14.XI.7.
   Google Scholar
• United Nations Office on Drugs and Crime (UNODC). 2016. World drug report 2017-market analysis of synthetic drugs Amphetamine-type stimulants, new psychoactive substances. Vienna, Austria: United Nations Office on Drugs and Crime
   Google Scholar
• United Nations Office on Drugs and Crime (UNODC). 2019. World drug report 2019. Vienna, Austria: United Nations Publication, Sales No. E.19.XI.8.
   Google Scholar
• van Gorp F, Wejden LC, Stienstra NA, Kuck EM, Haas LEM. 2017. Severe neurological symptoms following synthetic cannabinoid intoxication. Neth J Med. 75(4):158–160.
   PubMed Web of Science ®Google Scholar
• Welter-Luedeke J, Maurer HH. 2016. New psychoactive substances: chemistry, pharmacology, metabolism, and detectability of amphetamine derivatives with modified ring systems. Ther Drug Monit. 38(1):4–11.
   PubMed Web of Science ®Google Scholar
• Wicka M, Chołbiński P, Kwiatkowska D, Pokrywka A. 2014. Detection of psychotropic substances in the blood by LC/MS/MS method (in Polish). Problemy Kryminalistyki. 284(2):1–13.
   Google Scholar
• Wohlfarth A, Weinmann W, Dresen S. 2010. LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Anal Bioanal Chem. 396(7):2403–2414.
   PubMed Web of Science ®Google Scholar
• Yanes EG, Lovett DP. 2012. High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC–MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 909:42–50.
   PubMed Web of Science ®Google Scholar
• Yeter O. 2017. Determination of drugs in human blood via bidirectional solid phase extraction. LC-Tech Application Note 1–16. https://www.johnmorrisgroup.com/Content/Attachments/227518/LCTech-Application-Note-Drugs-Blood-en.pdf.
   Google Scholar